Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biomerica (BMRA) Operating Income (2016 - 2026)

Biomerica's Operating Income history spans 17 years, with the latest figure at -$1.3 million for Q1 2026.

  • On a quarterly basis, Operating Income fell 7.27% to -$1.3 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$5.4 million, a 312.84% decrease, with the full-year FY2025 number at -$5.1 million, down 511.95% from a year prior.
  • Operating Income hit -$1.3 million in Q1 2026 for Biomerica, up from -$1.4 million in the prior quarter.
  • Over the last five years, Operating Income for BMRA hit a ceiling of $6.1 million in Q2 2024 and a floor of -$2.1 million in Q3 2022.
  • Historically, Operating Income has averaged -$986168.8 across 5 years, with a median of -$1.4 million in 2025.
  • Biggest five-year swings in Operating Income: plummeted 1435.83% in 2023 and later soared 431.48% in 2024.
  • Tracing BMRA's Operating Income over 5 years: stood at -$1.7 million in 2022, then grew by 3.48% to -$1.6 million in 2023, then skyrocketed by 38.25% to -$993000.0 in 2024, then crashed by 38.27% to -$1.4 million in 2025, then increased by 5.46% to -$1.3 million in 2026.
  • Business Quant data shows Operating Income for BMRA at -$1.3 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.1 million in Q3 2025.